Gangley v. Immanuel Home Care Inc

On May 7, 2026, in Los Angeles, California, plaintiff Emily Gangley filed a wrongful death lawsuit against Immanuel Home Care Inc., a private home care agency. The suit alleges that over several days in late April 2026, two assigned caregivers neglected her 82-year-old father, Robert Gangley, who was recovering from hip surgery. The complaint states that aides failed to ensure adequate fluid intake and timely administration of heart medication, resulting in severe dehydration and a fatal cardiac arrest on May 2. Immanuel Home Care Inc. denies all allegations, contending that its staff followed the care plan and that the death was due to natural causes. An autopsy revealed dehydration as a contributing factor. The lawsuit seeks compensatory and punitive damages, accusing the company of negligent hiring, training, and supervision. The case has already prompted a bill in the state legislature to require licensing and regular inspections of home care agencies. The case underscores the vulnerability of elderly patients relying on for-profit home care providers and the legal gray area surrounding corporate accountability. Legal experts say it could set a precedent for holding home care companies criminally liable for neglect.

The case is currently in the discovery phase; a trial date has been set for late 2026. No settlement has been reached, and Immanuel Home Care Inc. has filed a motion for summary judgment, arguing that it met the standard of care.

The central dispute is whether Immanuel Home Care Inc. breached its duty of care through negligent supervision and omission by its caregivers, directly causing Robert Gangley's death, and whether the corporation can be held civilly or criminally liable for such systemic failures rather than merely the individual aides.

The case has intensified national scrutiny of the largely unregulated home care industry, triggering legislative proposals for mandatory caregiver training, background checks, and liability insurance. Elder advocacy groups view it as a landmark case that could establish clearer corporate accountability for patient safety.